Race and the clinic: Good science?

Scientist

Volumn 16, Issue 4, 2002, Pages 16-18

  Lewis, Ricki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CODEINE; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCOPROTEIN P; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTHROPOLOGY; CANCER; CAUSE OF DEATH; CLASSIFICATION; DECISION MAKING; DRUG METABOLISM; DRUG RESPONSE; ETHICS; ETHNOLOGY; EVOLUTION; GENETIC DISORDER; GENETIC TRAIT; HEALTH SERVICE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN GENOME; ISCHEMIC HEART DISEASE; MATING; MEDICAL PRACTICE; MIGRATION; NATURAL SELECTION; NEGRO; NOTE; PHARMACOGENETICS; PHENOTYPE; POPULATION GENETICS; RACE DIFFERENCE; REPRODUCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN COLOR;

EID: 0037128239     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. American Anthropological Association statement on race
2. Can race be erased? Coalitional computation and social categorization
3. Racial disparities in medical care
4. Racial profiling in medical research
5. Race and the response to adrenergic blockade with Carvedilol in patients with chronic heart failure
6. Lesser response to angiotensin-converting enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction
7. Racial differences in the response to drugs - Pointers to genetic differences
8. 3435T polymorphism of MDR1 gene in African people
9. Population genetic structure of variable drug response
10. Pharmacogenetics: More than skin deep